ATOX1 and melanoma: For example, the siRNA-mediated knockdown of ATOX1 in wild-type BRAF melanoma cells significantly diminished the accumulation of copper ions and reduced the susceptibility of cells to combination therapy with trametinib and disulfiram [144].